Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 206 of 6351
-
New drug gilteritinib may beat standard therapy in preventing AML relapse after transplant
Disease control Recruiting nowThe study population consisted of FLT3-ITD-mutated AML patients who were FLT3-ITD-positive before allogeneic hematopoietic stem cell transplantation. This open-label, randomized, controlled trial enrolled participants and randomly assigned them in a 1:1 ratio to either the experi…
Phase 3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
New combo therapy aims to stop liver cancer from coming back after surgery
Disease control Not yet recruitingThis study is designed to evaluate the efficacy and safety of sintilimab-bevacizumab doublet combined with FOLFOX-HAIC and TACE as the perioperative adjuvant therapy in surgical resection to hepatocellular carcinoma with high-risk features. (1) Evaluate for some high-risk patient…
Phase 1/2 • Sponsor: BinYong Liang • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Surgery plus drugs may extend life in advanced liver cancer
Disease control Not yet recruitingThis study will evaluate whether resection of the primary liver tumor, in addition to standard first-line systemic therapy, improves survival in patients with hepatocellular carcinoma that has spread outside the liver but still has a resectable primary intrahepatic tumor. Partici…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Mind-Controlled tech: brain implant trial aims to restore independence for paralysis patients
Disease control Recruiting nowThis is a prospective, open-label, multi-center, single-arm study to evaluate the efficacy and safety of an implantable wireless brain-machine interface (BMI) system in patients with spinal cord injury. Eligible participants will undergo screening after signing informed consent, …
Sponsor: Shanghai StairMed Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Parkinson's pain: could a new Add-On drug bring relief?
Symptom relief Recruiting nowThis is a Phase III, single-center, randomized, double-blind, placebo-controlled clinical trial designed to investigate the superiority of safinamide compared to a placebo in reducing Parkinson's Disease (PD)-related pain. The trial plans to enroll 60 adult patients diagnosed wi…
Phase 3 • Sponsor: Universita di Verona • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New drug combo aims to boost cervical cancer treatment
Disease control Recruiting nowThis study mainly evaluated the efficacy and safety of Cadonilimab combined with chemotherapy followed by concurrent chemoradiotherapy versus standard concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer.
Phase 3 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug aims to outperform chemo in tough bladder cancer
Disease control Recruiting nowResearchers are looking for new ways to treat locally advanced or metastatic urothelial cancer (UC). Current treatments for locally advanced or metastatic UC include chemotherapy, immunotherapy, and targeted therapy. Researchers want to know if giving sacituzumab tirumotecan (sa…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a Three-Drug combo quiet lupus kidney flares?
Disease control Recruiting nowThe goal of this clinical trial is to learn how different treatments affect immune cells in the kidney in people with active lupus nephritis (LN), a kidney manifestation of systemic lupus erythematosus (SLE). It will also investigate whether early changes in kidney tissue can pre…
Phase 4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Salt water infusion could boost brain injury recovery
Disease control Recruiting nowThe purpose of this study is to demonstrate the efficacy of early continuous intravenous infusion of hypertonic saline solution (HSS) to improve survival and independence in daily life activities (at 6 months) of patients with traumatic brain injury at high risk of intracranial h…
Phase 3 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Ambulance steroid shot may cut heart attack deaths, large trial underway
Disease control Recruiting nowBACKGROUND Myocardial reperfusion with the use of primary percutaneous coronary intervention (PCI) including stent implantation is the most efficacious treatment for patients with (STEMI) and improves prognosis significantly. Due to continuous improvements in the treatment, the m…
Phase 3 • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New shot could soothe severe eczema in teens
Disease control Not yet recruitingThis is a randomized, double-blind, placebo-controlled, parallel group study to confirm the efficacy and safety of MG-K10 monotherapy in adolescents with moderate-to-severe atopic dermatitis (AD)
Phase 3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New drug cocktail shows promise for untreated leukemia patients
Disease control Recruiting nowThis is a multicenter, prospective, single-arm clinical study designed to evaluate the efficacy and safety of the VA-CIG regimen (venetoclax combined with azacitidine, idarubicin, low-dose cytarabine and granulocyte colony-stimulating factor \[G-CSF\]) as induction therapy for pr…
Phase 2 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New clotting factor aims to stop bleeding in severe hemophilia a
Disease control OngoingThe indication for this product is to control bleeding in patients with hemophilia A (congenital deficiency of factor VIII). The primary objective: Evaluation of the efficacy of recombinant human coagulation factor VIII-Fc fusion protein for injection (FRSW107) as an on-demand …
Phase 3 • Sponsor: Hangzhou Gensciences Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Bladder cancer patients may avoid surgery with new drug combo
Disease control Recruiting nowThe goal of this clinical trial is to learn whether a combination of two chemotherapy drugs, Gemcitabine and Docetaxel, can treat high-grade non-muscle-invasive bladder cancer (HG-NMIBC) in adults whose cancer failed conventional BCG therapy. The drugs are given directly into the…
Phase 2 • Sponsor: Michael A. O'Donnell • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for ph+ ALL: targeted combo shows promise
Disease control Recruiting nowThis is an open-label, prospective clinical cohort study evaluating the efficacy and safety of reduced-intensity chemotherapy combined with targeted therapy and immunotherapy in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New lupus drug shows promise in major trial
Disease control Recruiting nowThis study will evaluate the efficacy and safety of MIL62 compared with placebo in participants with systemic lupus erythematosus.
Phase 3 • Sponsor: Beijing Mabworks Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a Direct-to-Tumor chemo blast halt advanced lung cancer?
Disease control By invitation onlyPatients with advanced non-small cell lung cancer (NSCLC) who experience disease progression after standard systemic therapies or are unable to tolerate such therapies have limited subsequent treatment options. Bronchial arterial chemoembolization (BACE) is a locoregional interve…
Phase 2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Viruses vs. infections: new hope for implant troubles?
Disease control Not yet recruitingA Prospective, Single-Center, Single-Arm Clinical Study with a Pre-Post Self-Controlled Design Evaluating the Efficacy and Safety of Bacteriophage Therapy for Refractory Orthopedic Implant-Associated Infections
Phase 3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for young leukemia patients: targeted chemo combo aims to boost treatment success
Disease control Recruiting nowThe goal of this research study is to evaluate a chemotherapy regiment for the treatment of newly diagnosed Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYAs). The names of the study drugs involved in this study are: * bli…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
One shot to prevent cancer: new HPV vaccine tested in zambia
Prevention Not yet recruitingThe goal of this study is to compare the immune response of the single dose of the CERVAVAC vaccine with the single dose of Gardasil vaccine in girls/women aged 9 to 20 and boys aged 9 to 14 at 6 months, 12 months and 24 months post vaccination. The vaccine will be given randomly…
Phase 4 • Sponsor: International Agency for Research on Cancer • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC